OXIS International Announces Joint Venture With Global Leading Digital Marketing Firm engage:BDR to Launch New EGT(TM) Based Health and Nutrition Product Line in April
Oxis International Inc.
17.04.2012 08:30
---------------------------------------------------------------------------
Global Online Digital Campaign Reaching Target Audience of 109 Million Expected
to Drive Significant Revenue
BEVERLY HILLS, Calif., 2012-04-17 08:30 CEST (GLOBE NEWSWIRE) --
OXIS International, Inc., (OTCBB:OXIS); (Paris:OXI) today announced its joint
venture with engage:BDR, a leading full-service digital advertising and
marketing agency, to launch its new antioxidant L-Ergothioneine (EGT(tm)) based
health and nutrition product line.
OXIS International is developing and manufacturing their proprietary EGT line
of products. engage:BDR will promote, market and create a full digital
advertising campaign for the line of health and nutrition products, reaching a
targeted audience of more than 109 million through its engage:BDR advertising
network and through mobile and video advertising.
'We have an unprecedented opportunity to introduce our proprietary EGT(tm) based
products direct to consumers with the help of our partners at engage:BDR,' said
David Saloff, Chairman and CEO, OXIS International. 'Their outstanding track
record executing direct-to-consumer products and ability to deliver our product
message to a very targeted audience will make for a very successful launch.'
EGT is referred to as the 'intelligent antioxidant' because it is the only
anti-oxidant having a dedicated transport mechanism in the body to deliver it
through the cell membrane and even into the mitochondria, the energy producing
area of the cell. Additionally, when other powerful antioxidants are also
present, the body preferentially utilizes ergothioneine. OXIS holds the
exclusive patent to manufacture EGT, which has received full GRAS (safety)
approval.
'OXIS International has illustrated tremendous expertise in product development
and manufacturing in creating the EGT product line which we're extremely
excited to deliver to the market,' said Ted Dhanik, president, engage:BDR.
'Engage:BDR delivers an end-to-end digital advertising services for companies
like OXIS to reach their audience, leveraging our extensive reach and
proprietary methodologies which we feel will boost their bottom line.'
ErgoFlex(tm) will be the first EGT-based product to launch. ErgoFlex is a unique,
clinically-proven dietary supplement for the rapid relief of joint pain and
improved mobility. ErgoFlex was successfully test marketed in a direct mail
campaign by OXIS in 2011. Additional products are expected to launch in early
summer.
About engage:BDR
engage:BDR provides advertisers cutting-edge marketing solutions, advanced
technology and custom programming by integrating display, video and branded
entertainment into a single network. Whether it's driving qualified traffic and
leads or building awareness and engagement, engage:BDR is committed to
providing innovative solutions to reach consumers and deliver the highest
quality results to their partners. Headquartered in Los Angeles, engage:BDR
attracts a list of top name partners and customers including Ask.com, Bose, CBS
Interactive, eHarmony, Live Nation, Sony Pictures among others.
About OXIS International, Inc.
OXIS International, Inc. develops technologies and products to research,
diagnose, treat and prevent diseases of oxidative stress/inflammation
associated with damage from free radical and reactive oxygen species (ROS). The
company holds the rights to several therapeutic classes of compounds in the
area of oxidative stress, including EGT(tm) (99% pure L-ergothioneine), known as
the intelligent antioxidant.
CONTACT: David Saloff
424-248 2311
David@Oxis.com
www.oxis.com
News Source: NASDAQ OMX
17.04.2012 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Oxis International Inc.
United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US6918294025
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Oxis International Inc.
17.04.2012 08:30
---------------------------------------------------------------------------
Global Online Digital Campaign Reaching Target Audience of 109 Million Expected
to Drive Significant Revenue
BEVERLY HILLS, Calif., 2012-04-17 08:30 CEST (GLOBE NEWSWIRE) --
OXIS International, Inc., (OTCBB:OXIS); (Paris:OXI) today announced its joint
venture with engage:BDR, a leading full-service digital advertising and
marketing agency, to launch its new antioxidant L-Ergothioneine (EGT(tm)) based
health and nutrition product line.
OXIS International is developing and manufacturing their proprietary EGT line
of products. engage:BDR will promote, market and create a full digital
advertising campaign for the line of health and nutrition products, reaching a
targeted audience of more than 109 million through its engage:BDR advertising
network and through mobile and video advertising.
'We have an unprecedented opportunity to introduce our proprietary EGT(tm) based
products direct to consumers with the help of our partners at engage:BDR,' said
David Saloff, Chairman and CEO, OXIS International. 'Their outstanding track
record executing direct-to-consumer products and ability to deliver our product
message to a very targeted audience will make for a very successful launch.'
EGT is referred to as the 'intelligent antioxidant' because it is the only
anti-oxidant having a dedicated transport mechanism in the body to deliver it
through the cell membrane and even into the mitochondria, the energy producing
area of the cell. Additionally, when other powerful antioxidants are also
present, the body preferentially utilizes ergothioneine. OXIS holds the
exclusive patent to manufacture EGT, which has received full GRAS (safety)
approval.
'OXIS International has illustrated tremendous expertise in product development
and manufacturing in creating the EGT product line which we're extremely
excited to deliver to the market,' said Ted Dhanik, president, engage:BDR.
'Engage:BDR delivers an end-to-end digital advertising services for companies
like OXIS to reach their audience, leveraging our extensive reach and
proprietary methodologies which we feel will boost their bottom line.'
ErgoFlex(tm) will be the first EGT-based product to launch. ErgoFlex is a unique,
clinically-proven dietary supplement for the rapid relief of joint pain and
improved mobility. ErgoFlex was successfully test marketed in a direct mail
campaign by OXIS in 2011. Additional products are expected to launch in early
summer.
About engage:BDR
engage:BDR provides advertisers cutting-edge marketing solutions, advanced
technology and custom programming by integrating display, video and branded
entertainment into a single network. Whether it's driving qualified traffic and
leads or building awareness and engagement, engage:BDR is committed to
providing innovative solutions to reach consumers and deliver the highest
quality results to their partners. Headquartered in Los Angeles, engage:BDR
attracts a list of top name partners and customers including Ask.com, Bose, CBS
Interactive, eHarmony, Live Nation, Sony Pictures among others.
About OXIS International, Inc.
OXIS International, Inc. develops technologies and products to research,
diagnose, treat and prevent diseases of oxidative stress/inflammation
associated with damage from free radical and reactive oxygen species (ROS). The
company holds the rights to several therapeutic classes of compounds in the
area of oxidative stress, including EGT(tm) (99% pure L-ergothioneine), known as
the intelligent antioxidant.
CONTACT: David Saloff
424-248 2311
David@Oxis.com
www.oxis.com
News Source: NASDAQ OMX
17.04.2012 Dissemination of a Corporate News, transmitted by DGAP -
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Oxis International Inc.
United States
Phone:
Fax:
E-mail:
Internet:
ISIN: US6918294025
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------